← boothcheck

HLN vs UL stock comparison

Haleon plc vs UNILEVER PLC, two Household Products stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Haleon focuses on consumer-health brands like Sensodyne and Advil, earning 15.23% margin at $83.0B. Unilever is a broader staples house spanning food and personal care, a shade wider at 19.82% margin and larger at $132.2B. Price is the sharp divide: Haleon trades at 39.25 times earnings, Unilever at 12.87, a threefold gap for two well-run consumer businesses. Free cash tilts to Unilever, 5.7% against 3.53%. Both keep clean balance sheets with no net debt. Haleon's book multiple sits at 3.98 while its return on equity runs 10.19%. Similar in quality and cash generation, yet the market pays far more per dollar of Haleon's profit than Unilever's.

Comparison updated 2026-07-11.

HLN vs UL: the numbers

MetricHLNUL
Price$9.77$61.73
Market cap$87.8B$134.8B
SectorHousehold ProductsHousehold Products
StageMatureMature
Implied growth (priced in)+16.2%
P/E41.513.1
P/B4.217.05
P/S6.292.46
EV/EBITDA24.511.6
Revenue growth+3.9%-0.4%
Gross margin64.2%47.0%
Operating margin21.9%17.9%
Net margin15.2%19.8%
Return on equity10.2%56.9%
Return on assets5.2%14.2%
Return on invested capital11.4%36.7%
FCF yield3.3%5.6%
Debt / equity0.000.00
Current ratio0.920.79
Altman Z (solvency)4.342.47
Piotroski F (quality)8 / 97 / 9
Full HLN report → Full UL report →
Get boothcheck's read on HLN and UL, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.